CNinsure Reports Second Quarter 2014 Unaudited Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CNinsure Reports Second Quarter 2014 Unaudited Financial Results

GUANGZHOU, China, Aug. 25, 2014 (GLOBE NEWSWIRE) -- CNinsure Inc, (Nasdaq: CISG ), (the "Company" or "CNinsure"), a leading independent insurance intermediary company operating in China, today announced its unaudited financial results for the second quarter ended June 30, 2014 1 .

Financial Highlights for Second Quarter of 201 4

  • Total net revenues : RMB508.9 million (US$82.0 million), representing an increase of 20.8% from the corresponding period in 2013.
     
  • Operating income : RMB18.7 million (US$3.0 million), representing an increase of 9,465.2% from the corresponding period in 2013.
     
  • Net income attributable to the Company's shareholders : RMB55.2 million (US$8.9 million), representing an increase of 163.8% from the corresponding period in 2013.
     
  • Basic and diluted net income per ADS : RMB1.10 (US$0.18) and RMB1.10 (US$0.18), respectively,representing an increase of 163.4% and 162.8% from the corresponding period in 2013, respectively.
     
  • Adjusted EBITDA 2 : RMB45.2 million (US$7.3 million), representing an increase of 57.4% from the corresponding period in 2013.
     
  • Diluted adjusted EBITDA per ADS : RMB0.90 (US$0.15), representing an increase of 57.0%from the corresponding period in 2013.

Commenting on the second quarter financial results, Mr. Chunlin Wang, CNinsure's chief executive officer, stated, "We are pleased to report significantly improved financial results for the second quarter of 2014, continuing the growth momentum of the prior two quarters. During the second quarter of 2014, total net revenues once again beat guidance, with 20.8% year-over-year growth, primarily driven by a strong growth across all of our business segments. In particular, our insurance brokerage business and claims adjusting business recorded impressive growth year-over-year while the life insurance agency business has finally yielded positive growth both year-over-year and quarter-over-quarter, after two years of negative growth. Our expense control initiatives continued to pay off, leading to major improvements in our operating income and earnings per share for three consecutive quarters.

"While expanding our off-line sales and service capabilities, we are dedicated to embracing the internet by establishing online financial product and services vertical portals and an online-to-offline ("O2O") ecological circle to support our offline operations. With a clear vision of our strategic direction, our goal, and the path to achieving it, we have rolled out several customer acquisition and online transaction platforms, including CNpad App and eHuzhu program ( www.ehuzhu.com ), a non-profit mutual aid platform. In the meantime, we have completed the restructuring of our offline operations which boasts a well-established nationwide sales and services network to provide our clients with the highest quality of financial products and services. Starting from the third quarter of 2014, we plan to push forward initiatives to strengthen our online customer acquisition and transaction platforms, and to seamlessly connect our offline sales and service capabilities with our online platforms. Several intensive marketing programs will also be initiated." Mr. Wang added, "In order to provide more visibility into the Company's growth prospects, we plan to host a corporate day in mid October to announce our O2O internet strategy and its impact on our financial results."

"We remain upbeat about our future and believe we have the right strategy and are on track to achieve strong sustainable growth over the long term."

Changes in Segment Reporting

In the first quarter of 2014, the Company realigned its financial reporting structure into four business segments that more accurately reflect its organizational structure and changing business mix. Historical results reflecting the new business segments for the corresponding period of the previous year are also presented in the Company's interim financial statements. Under the realigned business structure, the four business segments are as follows:

(1) insurance agency business segment, which mainly consists of providing agency services for property and casualty ("P&C") insurance products and life insurance products to individual clients,

(2) insurance brokerage business segment, which mainly consists of providing P&C and life insurance brokerage services to institutional clients,

(3) claims adjusting segment, which consists of providing pre-underwriting survey, claim adjusting, disposal of residual value, loading and unloading supervision and consulting services, and

(4) other services, which include non-insurance related services.

Financial Results for the Second Quarter of 201 4

Total net revenues were RMB508.9 million (US$82.0 million) for the second quarter of 2014, representing an increase of 20.8% from RMB421.3 million for the corresponding period in 2013.

Net revenues of insurance agency business were RMB379.4 million (US$61.2 million) for the second quarter of 2014, representing an increase of 9.7% from RMB345.9 million for the corresponding period in 2013. The increase was primarily driven by a 10.9% increase in net revenues derived from the P&C insurance agency business and a 2.7% increase in net revenues derived from the life insurance agency business. The growth of the P&C insurance agency business was primarily due to a 18.5% growth in sales volume, attributable to both solid organic growth and contributions from the acquisitions of three insurance agencies in the second quarter of 2014, offset by a slight decline in the commission rates that we received from the insurance companies for which we act as their agents. The growth of the life insurance agency business was primarily driven by a 36% increase in commissions derived from new policy sales, offset by a decline in renewal commissions resulting from a decline in new policy sales in the past two years and a decline in commissions derived from the sales of short term life insurance products. Revenues generated from insurance agency business accounted for 74.6% of total net revenues.

Net revenues of insurance brokerage business were RMB55.1 million (US$8.9 million) for the second quarter of 2014, representing an increase of 421.3% from RMB10.6 million for the corresponding period in 2013. The increase was primarily attributable to the low base in this segment during the second quarter of 2013 and an increase in our customer base as a result of efforts to expand sales channels, develop innovative product offerings and cultivate markets in the past three years. Revenues generated from the insurance brokerage business accounted for 10.8% of total net revenues.

Net revenues of claims adjusting business were RMB74.3 million (US$12.0 million) for the second quarter of 2014, representing an increase of 22.6% from RMB60.6 million for the corresponding period in 2013. The increase was primarily attributable to a 27.8% growth in the non-auto insurance related claims adjusting business in the second quarter of 2014 from the corresponding period in 2013 as the result of a significant increase in cases assigned to us and settled during the second quarter of 2014. In addition a 19.2% growth in the auto insurance related claims adjusting business which was due to both organic growth of existing branches and greater contributions from branches that were newly established in 2012 and 2013. Revenues generated from the claims adjusting business accounted for 14.6% of total net revenues.

Total operating costs and expenses were RMB490.1 million (US$79.0 million) for the second quarter of 2014, representing an increase of 16.4% from RMB421.1 million for the corresponding period in 2013.

Total operating costs were RMB376.1 million (US$60.6 million) for the second quarter of 2014, representing an increase of 20.1% from RMB313.0 million for the corresponding period in 2013. The increase was primarily due to sales growth.

Costs of insurance agency business were RMB291.7 million (US$47.0 million) for the second quarter of 2014, representing an increase of 8.5% from RMB268.9 million for the corresponding period in 2013, primarily driven by a 10.6% increase in costs for the P&C insurance agency business and offset by a 4.4% decrease in costs for the life insurance agency business. The growth in costs for the P&C insurance agency business was largely in line with the growth in net revenues of P&C insurance agency business while the decline in costs for the life insurance business was primarily attributable to a decline in costs associated with the renewal of life insurance policies. Costs incurred by the insurance agency business accounted for 77.6% of operating costs.

Costs of insurance brokerage business were RMB44.3 million (US$7.1 million) for the second quarter of 2014, representing an increase of 455.2% from RMB8.0 million for the corresponding period in 2013. The increase was primarily due to sales growth. Costs incurred by the insurance brokerage business accounted for 11.8% of operating costs.

Costs of claims adjusting business were RMB40.0 million (US$6.5 million) for the second quarter of 2014, representing an increase of 17.3% from RMB34.1 million for the corresponding period in 2013. The increase was primarily attributable to sales growth and increased salaries for claims adjustors. Costs incurred by the claims adjusting business accounted for 10.6% of operating costs.

Selling expenses were RMB24.4 million (US$3.9 million) for the second quarter of 2014, which was consistent with the corresponding period in 2013. This represents a decline in staff salary and social security contributions as a result of combining the operations of our P&C insurance and life insurance businesses in the fourth quarter of 2013, offset by increases in vehicle, office and marketing expenses.

General and administrative expenses were RMB89.7 million (US$14.5 million) for the second quarter of 2014, representing an increase of 7.2% from RMB83.7 million for the corresponding period in 2013. The slight increase was primarily due to:

(1) a 92.2% increase in research and development expenses, from RMB4.2 million for the second quarter of 2013 to RMB8.0 million (US$1.3 million) for the corresponding period in 2014;

(2) a 18.0% increase in staff salary expenses, from RMB27.5 million for the second quarter of 2013 to RMB32.5 million (US$5.2 million) for the corresponding period in 2014; offset by

(3) a 34.1% decrease in share-based compensation expenses, from RMB10.2 million for the second quarter of 2013 to RMB6.7 million (US$1.1 million) for the second quarter of 2014. Share-based compensation expenses were mainly associated with stock options granted to certain employees in March 2012, which were recognized on an accelerated basis and such expenses are expected to decrease each year after the grant.

As a result of the preceding factors, income from operations was RMB18.7 million (US$3.0 million) for the second quarter of 2014, representing an increase of 9,465.2% from RMB0.2 million for the corresponding period in 2013.

Operating margin was 3.7% for the second quarter of 2014, compared with 0.05% for the corresponding period in 2013.

Investment income was RMB17.1 million (US$2.8 million) for the second quarter of 2014, representing an increase of 1,193.8% from RMB1.3 million for the corresponding period in 2013. The increase was primarily attributable to an increase in the yields from trust products in which we began investing in March 2013 from RMB1.3 million to RMB8.3 million (US$1.3 million) in the second quarter of 2014 and the recognition of RMB8.8 million (US$1.4 million) in investment income relating to the revaluation of the 30% equity interests held by the Company in Jiaxing Lianbao Insurance Agency Co., Ltd. ("Jiaxing Lianbao") when it acquired the remaining 70% equity interests in the second quarter of 2014.

Interest income was RMB21.8 million (US$3.5 million) for the second quarter of 2014, representing an increase of 7.2% from RMB20.3 million for the corresponding period in 2013. The increase in interest income was primarily due to an increase in interest bearing receivables from related parties.

Income tax expense was RMB7.3 million (US$1.2 million) for the second quarter of 2014, representing an increase of 25.3% from RMB5.8 million for the corresponding period in 2013; mainly due to an increase in operating income. The effective tax rate for the second quarter of 2014 was 12.5% compared with 24.8% for the corresponding period in 2013. The decrease in effective tax rate was primarily due to the recognition of investment income relating to the revaluation gain for acquisition of the remaining equity interests in Jiaxing Lianbao and a tax holiday enjoyed by one of our subsidiaries.

Share of income of affiliates was RMB8.1 million (US$1.3 million) for the second quarter of 2014, representing an increase of 51.6% from RMB5.3 million for the corresponding period in 2013, mainly representing an increase of profits from China Financial Services Group Limited, in which we own 20.6% of the equity interests.

Net income attributable to the Company's shareholders was RMB55.2 million (US$8.9 million) for the second quarter of 2014, representing an increase of 163.8% from RMB20.9 million for the corresponding period in 2013.

Net margin was 10.9% for the second quarter of 2014 compared with 5.0% for the corresponding period in 2013.

Basic and diluted net income per ADS were RMB1.10 (US$0.18) and RMB1.10 (US$0.18) for the second quarter of 2014, respectively, representing increases of 163.4% and 162.8% from RMB0.42 and RMB0.42 for the corresponding period in 2013, respectively.

Adjusted EBITDA was RMB45.2 million (US$7.3 million) for the second quarter of 2014, representing an increase of 57.4% from RMB28.7 million for the corresponding period in 2013.

Adjusted EBITDA margin was 8.9% for the second quarter of 2014, compared with 6.8% for the corresponding period in 2013.

Diluted adjusted EBITDA per ADS was RMB0.90 (US$0.15) for the second quarter of 2014, representing an increase of 57.0% from RMB0.58 for the corresponding period in 2013.

As of June 30, 2014, the Company had RMB2.0 billion (US$323.8 million) in cash and cash equivalents .

Business Highlights :

  • As of June 30, 2014, 17,255 copies of the App had been downloaded and activated, of which 11,580 were downloaded and activated during the second quarter, and we had 8,218 active App users (defined as those who have made at least one transaction through App on their mobile devices since downloading the App). During the second quarter of 2014, insurance premiums generated through the App were RMB236.8 million in the second quarter 2014, up 667% year-over-year, accounting for 15.9% of total premiums of our P&C insurance agency business.
     
  • As of June 30, 2014, CNinsure's distribution and service network consisted of 536 sales and services outlets operating in 28 provinces, compared with 479 sales and service outlets operating in 27 provinces as of June 30, 2013. CNinsure had 54,383 sales agents and representatives and 1,516 professional claims adjustors as of June 30, 2014, compared with 47,554 sales agents and representatives, and 1,344 professional claims adjustors as of June 30, 2013.
     
  • During the second quarter of 2014, CNinsure completed electronic data interchange (the "EDI") connections with Sunshine Property and Casualty Insurance Company Limited ("Sunshine P&C"). As of June 30, 2014, the Company has already established EDI connections with Sunshine P&C, Taiping General Insurance Co., Ltd., Huatai Property Insurance Company, Ltd., Hua'an Property Insurance Co., Ltd., Dinghe Property Insurance Co., Ltd. and Alltrust Property Insurance Company Ltd. EDI connections allow for smoother data exchange and facilitate real-time quotations, applications, transactions and underwriting of the auto insurance products offered by the  connected companies through CNinsure's mobile sales support system. EDI connections with PICC Property and Casualty Co., Ltd. as well as China Life Property and Casualty Co., Ltd. are currently being developed.
     
  • On July 3, 2014, CNinsure launched eHuzhu ( www.ehuzhu.com ), the first non-profit online mutual aid platform in China. eHuzhu's first program targets the principal providers of families between the ages of 20 and 50, and offers financial aid of up to RMB500,000 to program members or their families should the provider be diagnosed with cancer or suffer an accidental death. Each program member pledges to donate up to RMB3 to the fund in each case of cancer or accidental death, and so the more members that sign up for the program the smaller the donation amount needed per case. As of August 25, 2014, there were 60,000 registered members on the platform and, of which over 49,000 have signed up for the program on eHuzhu's official website or through Wechat.
     
  • On July 1, 2014, Baoxian.com, an independent online insurance distributor in which CNinsure owns a majority of the equity interests, entered into an online distribution agreement with PICC Property and Casualty Company Limited ("PICC P&C"), the largest property and casualty insurance company in China. Travel insurance and personal accident insurance products from PICC P&C will be available at www.baoxian.com in the coming months. In addition to more customized accident insurance products, both parties will gradually extend their online distribution cooperation to include home owner insurance and personal liability insurance for mid-to-high end customers.    

As of June 30, 2014, Baoxian.com has partnered with over 20 insurance companies, including some major domestic insurance companies such as Ping An Property & Casualty Insurance Company of China, Ltd., China Pacific Property Insurance Co., Ltd., and offers over 500 accident, health, travel and homeowner insurance products online. 

Busine ss Outlook

CNinsure expects its total net revenues to grow by approximately 15% for the third quarter of 2014 compared with the corresponding period in 2013. This forecast reflects CNinsure's current view, which is subject to change.

Conference Call

The Company will host a conference call to discuss the second quarter 2014 results as per the following details.

Time:  9:00 PM Eastern Daylight Time on August 25, 2014
  or 9:00 AM Beijing/Hong Kong Time on August 26, 2014
   
The toll free dial-in numbers:  
United States 1-855-500-8701
United Kingdom 0800-015-9724
Canada 1-855-757-1565
Taiwan 0080-665-1951
Hong Kong  800-903-737
   
The toll dial-in numbers:  
China (Mainland) 400-120-0654
Singapore & Other Areas +65-6723-9385

A replay of the call will be available for 7 days by dialing the following number: +61-2-9003-4211

Conference ID #:87267961

Additionally, a live and archived web cast of this call will be available at:  http://ir.cninsure.net/events.cfm

About CNinsure Inc .

CNinsure is a leading independent insurance intermediary company operating in China. CNinsure's distribution network reaches many of China's most economically developed regions and affluent cities. The Company distributes a wide variety of property and casualty and life insurance products underwritten by domestic and foreign insurance companies operating in China, and provides insurance claims adjusting as well as other insurance-related services.

Forward-looking Statements

This press release contains statements of a forward-looking nature. These statements, including the statements relating to the Company's future financial and operating results, are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by terminology such as "will," "expects," "believes," "anticipates," "intends," "estimates" and similar statements. Among other things, management's quotations and the Business Outlook section contain forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about CNinsure and the industry. Potential risks and uncertainties include, but are not limited to, those relating to CNinsure's limited operating history, especially its limited experience in selling life insurance products, its ability to attract and retain productive agents, especially entrepreneurial agents, its ability to maintain existing and develop new business relationships with insurance companies, its ability to execute its growth strategy, its ability to adapt to the evolving regulatory environment in the Chinese insurance industry, its ability to compete effectively against its competitors, quarterly variations in its operating results caused by factors beyond its control and macroeconomic conditions in China and their potential impact on the sales of insurance products. All information provided in this press release is as of the date hereof, and CNinsure undertakes no obligation to update any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although CNinsure believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that its expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results. Further information regarding risks and uncertainties faced by CNinsure is included in CNinsure's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F.

About Non-GAAP Financial Measures

In addition to the Company's consolidated financial results under GAAP, the Company also provides adjusted EBITDA, adjusted EBITDA margin and diluted adjusted EBITDA per ADS, which are non-GAAP financial measures. Adjusted EBITDA is defined as net income before income tax expense, investment income, interest income, depreciation, amortization and compensation expenses associated with stock option. Adjusted EBITDA margin is defined as adjusted EBITDA divided by total net revenues. Diluted adjusted EBITDA per ADS is defined as adjusted EBITDA divided by total number of diluted shares. The Company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing the Company's performance and when planning and forecasting future periods. One limitation of using these non-GAAP financial measures is that these non-GAAP measures exclude the items that were significant in the second quarter of 2014 and the corresponding period of 2013, and these items have been, and will continue to be, a significant recurring factor in our business.

In light of the limitations, the presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. We encourage investors and other interested persons to review our financial information in its entirety and not rely on a single financial measure. For more information on these non-GAAP financial measures, please see the tables captioned "Reconciliations of Net Income to Adjusted EBITDA and Adjusted EBITDA Margin" set forth at the end of this release.

1 This announcement contains currency conversions of certain Renminbi (RMB) amounts into U.S. dollars (US$) at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to U.S. dollars are made at a rate of RMB6.2036 to US$1.00, the effective noon buying rate as of June 30, 2014 in The City of New York for cable transfers of RMB as set forth in H.10 weekly statistical release of the Federal Reserve Board.

2 Adjusted EBITDA is defined as net income before income tax expense, investment income, interest income, depreciation, amortization and compensation expenses associated with stock option.

CNINSURE INC.
Condensed Consolidated Balance Sheets
(In thousands)
       
  As of December 31, 2013 As of June 30, 2014 As of June 30, 2014
  RMB RMB US$
  (audited) (unaudited) (unaudited)
ASSETS:      
Current assets:      
Cash and cash equivalents  2,288,623 2,008,608 323,781
Restricted cash  11,100 10,618 1,712
Short term investments  253,900 598,900 96,541
Accounts receivable, net  199,482 191,551 30,877
Insurance premium receivables  57 915 148
Other receivables  254,776 208,796 33,657
Deferred tax assets  4,858 — —
Amounts due from related parties  144,371 219,474 35,378
Other current assets  20,634 25,554 4,119
Total current assets 3,177,801 3,264,416 526,213
       
Non-current assets:      
Property, plant, and equipment, net  69,562 57,500 9,269
Goodwill and intangible assets, net  107,668 174,523 28,133
Deferred tax assets  3,382 2,489 401
Investment in affiliates  189,241 203,523 32,807
Other non-current assets  13,076 12,676 2,043
Total non-current assets 382,929 450,711 72,653
Total assets 3,560,730 3,715,127 598,866
       
LIABILITIES AND EQUITY:      
Current liabilities:      
Accounts payable (including accounts payable of the consolidated variable interest entities ("VIEs") without recourse to CNinsure Inc. of RMB10,282 and RMB2,967 (US$478) as of December 31, 2013 and June 30, 2014, respectively)  92,324 101,082 16,294
Insurance premium payables (including insurance premium payables of the consolidated VIEs without recourse to CNinsure Inc. of RMB223 and RMB515 (US$83) as of December 31, 2013 and June 30, 2014, respectively)  4,066 4,408 711
Other payables and accrued expenses (including other payables and accrued expense of the consolidated VIEs without recourse to CNinsure Inc. of RMB21,129 and RMB17,231 (US$2,778) as of December 31, 2013 and June 30, 2014, respectively)  147,954 186,458 30,056
Accrued payroll (including accrued payroll of the consolidated VIEs without recourse to CNinsure Inc. of RMB2,172 and RMB1,204 (US$194) as of December 31, 2013 and June 30, 2014, respectively)  39,089 35,590 5,737
Income tax payable (including income tax payable of the consolidated of VIEs without recourse to CNinsure Inc. of RMB2,603 and RMB2,603 (US$420) as of December 31, 2013 and June 30, 2014, respectively)  55,992 54,068 8,716
Total current liabilities 339,425 381,606 61,514
       
Non-current liabilities:      
Other tax liabilities  50,735 46,829 7,549
Deferred tax liabilities  23,808 26,998 4,352
Total non-current liabilities 74,543 73,827 11,901
Total liabilities 413,968 455,433 73,415
       
Ordinary shares  7,624 7,634 1,231
Additional paid-in capital  2,329,962 2,335,937 376,545
Statutory reserves  182,740 182,740 29,457
Retained earnings  618,885 718,789 115,866
Accumulated other comprehensive loss  (111,114) (105,477) (17,003)
Total CNinsure Inc. shareholders' equity 3,028,097 3,139,623 506,096
Non-controlling interests  118,665 120,071 19,355
Total equity 3,146,762 3,259,694 525,451
Total liabilities and equity 3,560,730 3,715,127 598,866
 
CNINSURE INC.
             
Condensed Consolidated Statements of Income and Comprehensive Income
( In thousands, except for shares and per share data )
             
  For The Three Months Ended For The Six Months Ended
  June 30, June 30,
  2013 2014 2014 2013 2014 2014
  RMB  RMB US$ RMB RMB US$
  (unaudited) (unaudited) (unaudited) (unaudited) (unaudited) (unaudited)
Net revenues:            
Revenues of insurance agency business  345,907 379,405 61,158 689,204 731,003 117,835
Revenues of insurance brokerage business  10,575 55,124 8,886 13,790 106,187 17,117
Revenues of claims adjusting business  60,645 74,324 11,981 112,866 137,867 22,224
Revenues of other services  4,162 — — 6,691 — —
Total net revenues 421,289 508,853 82,025 822,551 975,057 157,176
Operating costs and expenses:            
Costs of insurance agency business  (268,876) (291,744) (47,028) (533,593) (556,933) (89,776)
Costs of insurance brokerage business  (7,988) (44,346) (7,148) (10,469) (84,136) (13,562)
Costs of claims adjusting business  (34,110) (40,013) (6,450) (62,037) (77,533) (12,498)
Costs of other services  (2,070) — — (4,114) — —
Total operating costs (313,044) (376,103) (60,626) (610,213) (718,602) (115,836)
Selling expenses  (24,364) (24,362) (3,927) (44,467) (48,568) (7,829)
General and administrative expenses  (83,686) (89,671) (14,455) (166,067) (175,960) (28,364)
Total operating costs and expenses (421,094) (490,136) (79,008) (820,747) (943,130) (152,029)
Income from operations 195 18,717 3,017 1,804 31,927 5,147
Other income, net:            
Investment income  1,320 17,078 2,753 1,320 24,251 3,909
Interest income  20,323 21,791 3,513 41,868 44,016 7,095
Others, net  1,533 466 75 1,642 660 106
Income before income taxes and income of affiliates 23,371 58,052 9,358 46,634 100,854 16,257
Income tax expense  (5,802) (7,268) (1,172) (12,035) (14,536) (2,343)
Share of income of affiliates  5,310 8,050 1,298 10,644 14,469 2,332
Net income 22,879 58,834 9,484 45,243 100,787 16,246
Less: net gain attributable to noncontrolling interests  1,953 3,631 585 3,289 883 142
Net income attributable to the Company's shareholders 20,926 55,203 8,899 41,954 99,904 16,104
             
Net income per share: 0.02 0.06 0.01 0.04 0.10 0.02
Basic             
Diluted  0.02 0.05 0.01 0.04 0.10 0.02
Net income per ADS:            
Basic  0.42 1.10 0.18 0.84 2.00 0.32
Diluted  0.42 1.10 0.18 0.84 1.99 0.32
             
Shares used in calculating net income per share: 998,861,526 1,000,294,943 1,000,294,943 998,861,526 999,603,760 999,603,760
Basic             
Diluted  1,002,321,530 1,006,066,521 1,006,066,521 1,002,278,510 1,004,712,385 1,004,712,385
  22,879 58,834 9,484 45,243 100,787 16,246
Net income            
Other comprehensive (loss) income, net of tax: Foreign currency translation adjustments  (2,931) (468) (75) (3,686) 5,637 909
Comprehensive income 19,948 58,366 9,409 41,557 106,424 17,155
Less: Comprehensive income attributable to the noncontrolling interests  1,953 3,631 585 3,289 883 142
Comprehensive income attributable to the CNinsure Inc's shareholders 17,995 54,735 8,824 38,268 105,541 17,013
 
CNINSURE INC.
Condensed Consolidated Statements of Cash Flow
( In thousands )
             
  For The Three Months Ended For The Six Months Ended
  June 30, June 30,
  2013 2014 2014 2013 2014 2014
  RMB RMB US$ RMB RMB US$
  (unaudited) (unaudited) (unaudited) (unaudited) (unaudited) (unaudited)
OPERATING ACTIVITIES            
Net income 22,879 58,834 9,484 45,243 100,787 16,246
Adjustments to reconcile net income to net cash generated from operating activities:            
Depreciation  8,073 7,447 1,200 16,009 15,139 2,440
Amortization of intangible assets  3,416 3,818 615 6,832 7,234 1,166
Allowance for doubtful receivables  447 1,419 229 1,196 3,128 504
Compensation expenses associated with stock option  10,202 6,722 1,084 22,982 14,326 2,309
Gain on disposal of property, plant and equipment  (16) (54) (9) (16) (85) (14)
Investment income  — (10,670) (1,720) — (10,670) (1,720)
Share of income of affiliates  (5,310) (8,050) (1,298) (10,644) (14,469) (2,332)
Changes in operating assets and liabilities  11,900 24,195 3,901 (38,411) 17,368 2,800
Net cash generated from operating activities 51,591 83,661 13,486 43,191 132,758 21,399
             
Cash flows generated from(used in) investing activities:            
Purchase of property, plant and equipment  (27,221) (1,493) (241) (32,719) (2,945) (475)
Proceeds from disposal of property and equipment  16 307 49 30 358 58
Proceeds from disposal of short term investments  600 16,859 2,718 600 16,859 2,718
Purchase of short term investments  (138,900) (310,000) (49,971) (233,900) (360,000) (58,031)
Acquisition of subsidiaries, net of cash — 1,015 164 — 1,015 164
(Increase) decrease in restricted cash  (1,013) 8,167 1,316 (1,179) 482 78
Decrease (increase) in other receivables  — 35,700 5,755 — (5,055) (815)
Purchase of intangible assets  — (118) (19) — (118) (19)
Return of investment in non-current assets — — — — 400 65
(Increase) decrease in amounts due from related parties  (24,931) (43,488) (7,010) 15,140 (72,589) (11,701)
Net cash used in investing activities (191,449) (293,051) (47,239) (252,028) (421,593) (67,958)
             
Cash flows generated from financing activities:            
Capital injection by noncontrolling interests  — — — 2,450 — —
Proceeds on exercise of stock options  — 837 135 — 3,183 513
Net cash generated from financing activities — 837 135 2,450 3,183 513
             
Net decrease in cash and cash equivalents (139,858) (208,553) (33,618) (206,387) (285,652) (46,046)
Cash and cash equivalents at beginning of period 2,458,334 2,217,629 357,474 2,525,618 2,288,623 368,918
Effect of exchange rate changes on cash and cash equivalents  (2,931) (468) (75) (3,686) 5,637 909
Cash and cash equivalents at end of period 2,315,545 2,008,608 323,781 2,315,545 2,008,608 323,781
             
Interest paid  — — — — — —
Income taxes paid  5,275 6,419 1,035 14,772 14,390 2,320
 
CNINSURE INC.
Reconciliations of Net Income to Adjusted EBITDA and Adjusted EBITDA Margin
(In thousands)
             
  For The Three Months Ended For The Six Months Ended
  June 30, June 30,
  2013 2014 2014 2013 2014 2014
  RMB RMB US$ RMB RMB US$
  (unaudited) (unaudited) (unaudited) (unaudited) (unaudited ) (unaudited)
Net income 22,879 58,834 9,484 45,243 100,787 16,246
Income tax expense  5,802 7,268 1,172 12,035 14,536 2,343
Investment income  (1,320) (17,078) (2,753) (1,320) (24,251) (3,909)
Interest income  (20,323) (21,791) (3,513) (41,868) (44,016) (7,095)
Depreciation  8,073 7,447 1,200 16,009 15,139 2,440
Amortization of intangible assets  3,416 3,818 615 6,832 7,234 1,166
Compensation expenses associated with stock option  10,202 6,722 1,084 22,982 14,326 2,309
Adjusted EBITDA 28,729 45,220 7,289 59,913 83,755 13,500
Total net revenues  421,289 508,853 82,025 822,551 975,057 157,176
Adjusted EBITDA Margin 6.8% 8.9% 8.9% 7.3% 8.6% 8.6%

For more information, please contact: Oasis Qiu Investor Relations Manager Tel: +86 (20) 6122-2731 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Kinetic Seas Incorporated Secures First Customer Success

Updated Category News Views 56

Kinetic Seas Incorporated Secures First Customer and Financial Growth Kinetic Seas Incorporated (OTC: ECGR) is excited to announce the signing of its first customer, along with impressive revenue results for the second quarter. This milestone marks a significant step forward as the company pursues its goals in the artificial intelligence sector. Second Quarter Revenue...

Continue Reading
Webinar Guide for Veterans to Maximize Benefits Offered by CCK Law

Updated Category News Views 134

Helping Veterans Discover VA Benefits with a Free Webinar Chisholm Chisholm & Kilpatrick LTD (CCK Law), a preeminent veterans disability law firm, is excited to introduce a free, on-demand webinar aimed at assisting veterans in uncovering valuable VA benefits that many may be unaware of. Insights from the Experts The webinar, dubbed "Biggest Benefits Veterans Overlook,"...

Continue Reading
Tech Market Shifts: Navigating Opportunities and Challenges Ahead

Updated Category News Views 161

Understanding Recent Market Dynamics In recent weeks, global markets have been experiencing heightened volatility, particularly in the technology sector. With various significant events unfolding—including new political leadership in Japan and shifts in economic data—investors are carefully analyzing these developments to navigate potential risks and opportunities....

Continue Reading
Michael Beland Joins Advance Auto Parts as Chief Accounting Officer

Updated Category News Views 720

Welcome Michael Beland to Advance Auto Parts Advance Auto Parts, Inc. (NYSE: AAP), known for its significant role in the automotive aftermarket, recently made an important announcement regarding its executive leadership. The company has appointed Michael Beland as the new senior vice president, controller, and chief accounting officer, marking a pivotal addition to their...

Continue Reading
Recall Movement Against Governor Newsom Gains Momentum

Updated Category News Views 276

Recall Movement Gains Traction in California In an unprecedented move, SavingCalifornia.vote has taken a significant step to initiate a recall against Governor Gavin Newsom. This initiative marks a pivotal moment in California's political landscape. The organization is gathering support and will soon submit the official notice of intent to recall, alongside the necessary...

Continue Reading